ArticleActa parasitologica2026
Antibody Recognition and Functional Activity Against a Conserved Trypanosoma cruzi Peptide and Its Natural Variants in Kinetoplastids.
Article in Acta parasitologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe TcTLE peptide (TLEEFSAKL), located at the amino-terminus of the Trypanosoma cruzi Kinetoplastid Membrane Protein-11 (KMP-11), induces robust humoral and cellular immune responses, suggesting its potential for serological diagnostics or immunoprophylaxis. However, natural variants of this sequence exist in Leishmania spp. This study aims to assess the humoral specificity toward this epitope.
methodsKMP-11 sequences were retrieved from the UniProtKB database. Multiple sequence alignment was conducted using the CLUSTALW alignment tool. In silico analysis of the peptides was performed using I-TASSER. Alanine scan derivates as well as chemically synthesized TcTLE, TcY (TYEEFSAKL), and TcYA (TYEEFAAKL) peptides were tested by ELISA using both a monoclonal antibody (mAb) and polyclonal rabbit sera raised against TcTLE. Additional analyses included indirect immunofluorescence assay (IFAT) and flow cytometry with T. cruzi epimastigotes (TcTLE), Leishmania amazonensis (TcY), and Leishmania panamensis (TcYA) promastigotes. Invasion assays were carried out with susceptible cells and T. cruzi trypomastigote CFSE labeling.
resultsBy ELISA, both mAb and polyclonal sera recognized TcY but showed minimal reactivity to TcYA. Alanine scanning revealed that residue 2 is not critical for antibody recognition. In IFAT, the mAb failed to bind fixed parasites, whereas in flow cytometry it bound live T. cruzi epimastigotes but not Leishmania promastigotes. The anti-TcTLE mAb significantly reduced T. cruzi cell invasion in vitro.
conclusionOverall, although the TcY variant was recognized in vitro, antibodies to TcTLE did not detect parasites expressing the KMP-11 variants, indicating that true cross-reactivity with Leishmania is unlikely.
Indexed as
Identifiers
42635860What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.